Inhibition of viral assembly in murine cells by HIV-1 matrix

Wolfgang Hübner1, Benjamin K Chen

  • 1Department of Pharmacology and Biological Chemistry, Center for Immunobiology, Mount Sinai School of Medicine, One Gustave Levy Place Box 1215, New York, NY 10029, USA.

Virology
|June 6, 2006
PubMed

Insights

Murine leukemia virus (MLV) matrix (MA) enhances human immunodeficiency virus type 1 (HIV-1) Gag membrane binding in murine cells. However, efficient HIV-1 assembly requires removing HIV-1 MA and involves host factors interacting with MA's globular head.

Area of Science:

  • Virology
  • Molecular Biology
  • Cell Biology

Background:

  • The N-terminal matrix (MA) domain of human immunodeficiency virus type 1 (HIV-1) Gag is crucial for targeting viral assembly to specific cellular membrane compartments.
  • HIV-1 Gag assembly and membrane targeting are inefficient in murine fibroblasts compared to human cells.
  • Chimeric proviruses with murine leukemia virus (MLV) MA can rescue these deficiencies.

Purpose of the Study:

  • To investigate the role of MLV MA in enhancing HIV-1 Gag membrane binding and assembly in murine cells.
  • To determine the specific domains of MA involved in cell-type-specific assembly phenotypes.
  • To elucidate the interaction between MA and host factors in regulating viral assembly.

Main Methods:

  • Construction and analysis of chimeric HIV-1 proviruses containing tandem MLV and HIV-1 MA domains.
  • Assessment of Gag membrane binding efficiency in murine cells.
  • Evaluation of Gag processing and virus production in murine cells.
  • Site-directed mutagenesis to delete the globular head of MA.

Main Results:

  • Addition of MLV MA to HIV-1 Gag enhanced membrane binding in murine cells but did not fully restore virus production.
  • Removal of HIV-1 MA was necessary for efficient Gag processing and increased virus production in murine cells.
  • Deletion of the MA globular head partially restored membrane binding and Gag processing but did not enhance virus production.

Conclusions:

  • MA-dependent, cell-type-specific phenotypes indicate a complex regulation of HIV-1 assembly.
  • Host factors likely interact with the globular head of MA to regulate membrane binding.
  • Additional membrane-independent steps are critical for efficient viral assembly, influenced by MA-host factor interactions.

Related Concept Videos

Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...